Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cytomegalovirus Infection

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    July 2021
  1. KANG HM, Kim SK, Ryu IH, Lee JW, et al
    Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
    PubMed     Abstract available


    May 2021
  2. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
    T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
    PubMed     Abstract available


  3. STYCZYNSKI J, Tridello G, Xhaard A, Medinger M, et al
    Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
    Bone Marrow Transplant. 2021;56:1171-1179.
    PubMed     Abstract available


    January 2021
  4. YOKOYAMA H, Kanda J, Kawahara Y, Uchida N, et al
    Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01203.
    PubMed     Abstract available


    December 2020
  5. BEAUVAIS D, Drumez E, Blaise D, Peffault de Latour R, et al
    Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.
    Bone Marrow Transplant. 2020 Dec 18. pii: 10.1038/s41409-020-01178.
    PubMed     Abstract available


  6. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
    Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
    PubMed     Abstract available


  7. MORI T, Kikuchi T, Koh M, Koda Y, et al
    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
    PubMed     Abstract available


    November 2020
  8. MORI Y, Jinnouchi F, Takenaka K, Aoki T, et al
    Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01082.
    PubMed     Abstract available


    August 2020
  9. KANG SH, Yoo JW, Seo JK, Kim H, et al
    The role of interim-foscarnet prophylaxis in preventing cytomegalovirus infection after ex vivo alphabeta T cell-depleted haploidentical hematopoietic cell transplant in children.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01020.
    PubMed    


    May 2020
  10. HUNTLEY D, Gimenez E, Pascual MJ, Vazquez L, et al
    Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0950.
    PubMed    


    April 2020
  11. CARAPITO R, Aouadi I, Pichot A, Spinnhirny P, et al
    Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0886.
    PubMed     Abstract available


    March 2020
  12. HUNTLEY D, Gimenez E, Pascual MJ, Remigia MJ, et al
    Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 Mar 23. pii: 10.1038/s41409-020-0865.
    PubMed     Abstract available


    January 2020
  13. YAN CH, Wang Y, Mo XD, Sun YQ, et al
    Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jan 28. pii: 10.1038/s41409-020-0790.
    PubMed     Abstract available


    October 2019
  14. SHARMA P, Gakhar N, MacDonald J, Abidi MZ, et al
    Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation.
    Bone Marrow Transplant. 2019 Oct 29. pii: 10.1038/s41409-019-0730.
    PubMed     Abstract available


    September 2019
  15. PARK HJ, Hong KT, Yun SO, Ahn HY, et al
    Successful treatment of refractory CMV colitis after haploidentical HSCT with post-transplant cyclophosphamide using CD45RA(+) depleted donor lymphocyte infusion.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0685.
    PubMed    


    November 2018
  16. KNOLL BM, Seiter K, Phillips A, Soave R, et al
    Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0389.
    PubMed    


  17. YOKOYAMA H, Kanda J, Kato S, Kondo E, et al
    Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0369.
    PubMed     Abstract available


    June 2018
  18. EVA V, Lenka P, Petr H, Milan K, et al
    Clinical and genotypic CMV drug resistance in HSCT recipients: a single center epidemiological and clinical data.
    Bone Marrow Transplant. 2018 Jun 27. pii: 10.1038/s41409-018-0257.
    PubMed    


  19. SOLANO C, Gimenez E, Albert E, Mateo EM, et al
    Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0251.
    PubMed     Abstract available


    May 2018
  20. METAFUNI E, Chiusolo P, Sica S, Laurenti L, et al
    Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0200.
    PubMed     Abstract available


  21. LINDEMANN M, Eiz-Vesper B, Steckel NK, Tischer S, et al
    Adoptive transfer of cellular immunity against cytomegalovirus by virus-specific lymphocytes from a third-party family donor.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0209.
    PubMed    


    April 2018
  22. SOLANO C, Talaya A, Gimenez E, Albert E, et al
    Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0191.
    PubMed    


  23. PERIC Z, Wilson J, Durakovic N, Ostojic A, et al
    Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0172.
    PubMed     Abstract available


  24. ALSULIMAN T, Kitel C, Dulery R, Guillaume T, et al
    Cytotect(R)CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study.
    Bone Marrow Transplant. 2018 Apr 13. pii: 10.1038/s41409-018-0166.
    PubMed     Abstract available


    January 2018
  25. CESARO S, Crocchiolo R, Tridello G, Knelange N, et al
    Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0016.
    PubMed     Abstract available


    October 2017
  26. ALBERT E, Solano C, Gimenez E, Focosi D, et al
    The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


    June 2017
  27. SOLANO C, Gimenez E, Pinana JL, Hernandez-Boluda JC, et al
    When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed    


    February 2017
  28. IGLESIAS L, Perera MM, Torres-Minana L, Pena-Lopez MJ, et al
    CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


    January 2017
  29. SHAW BE, Mayor NP, Szydlo RM, Bultitude WP, et al
    Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Abstract available


    October 2016
  30. BAO X, Zhu Q, Xue S, Xu Y, et al
    Risk factors of clinically refractory CMV reactivation following allogeneic HSCT: a single-center study in China.
    Bone Marrow Transplant. 2016 Oct 17. doi: 10.1038/bmt.2016.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: